MA
Michael S Anderson
Chief Executive OfficerDirector

Michael S Anderson insider trades: Avadel Pharmaceuticals (AVDL) stock buys and sales

Chief Executive Officer, Avadel Pharmaceuticals Last trade Aug 10, 2018 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2016
2
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 10, 2018AVDL↓ Sell$80K
Jun 26, 2018AVDL↑ Buy$15K
May 24, 2018AVDL↑ Buy$19K
Dec 7, 2017AVDL↑ Buy$44K
Sep 12, 2017AVDL↑ Buy$39K
May 19, 2017AVDL↑ Buy$25K
Nov 21, 2016FLML↑ Buy$21K
Sep 2, 2016FLML↑ Buy$28K
Aug 22, 2016FLML↑ Buy$71K
May 12, 2016FLML↑ Buy$44K
Mar 18, 2016FLML↑ Buy$55K
Mar 14, 2016FLML↑ Buy$97K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVDL insiders

Open-market trades in the last 12 months

About Michael S Anderson's insider trades

Michael S Anderson is Chief Executive Officer at Avadel Pharmaceuticals (AVDL). Since Mar 14, 2016, Michael has reported 11 open-market purchases worth $461K and 1 sale worth $80K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.